Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsy
Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsy
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Cenobamate is a recently approved antiseizure medication that proved to be safe and effective in randomized controlled trials. However, little is known about its impact on some areas frequently affected by epilepsy. For this reason, we explored the effects of cenobamate on cognitive performance, as well as on negative affectivity and quality of lif...
Alternative Titles
Full title
Prospective study of cenobamate on cognition, affectivity, and quality of life in focal epilepsy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6deaef99f36f47569d00e0fddb6aaf7c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6deaef99f36f47569d00e0fddb6aaf7c
Other Identifiers
ISSN
2470-9239
E-ISSN
2470-9239
DOI
10.1002/epi4.12857
